Carlton South Vic 3053, Australia
Go to Investors Hub
info@radiopharmtheranostics.com

Dosing begins in Phase 1 Pancreatic Imaging Study of RAD 301

Leave a Reply

Your email address will not be published.Required fields are marked *

More Announcements & Updates

Change in substantial holding – NT
Response to ASX Aware Letter
Change in substantial holding – PH
RAD increases ownership in Radiopharm Ventures to 75%
Categories
Announcements
Announcements
Annual Reports
Annual Reports
Presentations
Presentations
News
News
Recent News
Analyst ReportsAnnouncementsAnnual ReportsInvestor PresentationsRAD ArticlesUpdates
Tags
Tags
Appendix 2A (1) Appendix 3B (1) Change of Director's Interest Notice (1) Cleansing Notice (1) PDF (22) Periodic Reports (24) Price Sensitive (84) Progress Report (2) Video (3) With Summary (2) With Video (4)
Archives
Archives
RSS RSS
Close
Search

Hit enter to search or ESC to close

cookie By using this website, you agree to our cookie policy. Close